Table II. Characteristics of the licensed vaccines used in whole blood assays.
| Vaccine | Trade name | Abbreviation | Manufacturer | Adjuvant |
|---|---|---|---|---|
| Hepatitis B | Recombivax HB | HepB | Merck | AAHS |
| Human Papillomavirus | Cervarix | 2vHPV | GlaxoSmithKline | Al(OH)3, MPLA |
| H. influenzae type b, Meningococcal | PedvaxHIB | Hib-MenB | Merck | AAHS, OMPC |
| Meningococcal | Bexsero | MenB | GlaxoSmithKline | Al(OH)3, OMVs |
| Hepatitis B, Diphtheria, Tetanus, Pertussis, H. influenzae type b, | Easyfive | DTwP-Hep B-Hib | Panacea Biotec | AlPO, Inactivated whole cell B. pertussis |
Table adapted from Centers for Disease Control and Prevention Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition. Abbreviations. AAHS; Amorphous Aluminum Hydroxyphosphate Sulfate, AlPO; Aluminum Phosphate, Al(OH)3; Aluminum Hydroxide, MPLA; Monophosphoryl Lipid A, OMVs; Outer Membrane Vesicles, OMPC; Outer Membrane Protein Complex.